HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon
A serosurvey for Human T-cell Lymphotropic virus type 1 (HTLV-I)/HTLV-II was conducted in 1,900 blood donors, 120 pregnant women and 436 high-risk group patients in Beirut, Lebanon. One of the 1,900 blood donors was anti-HTLV-I/II—seroreactive on screening by enzyme immunoassay (EIA) but was indeter...
محفوظ في:
| المؤلف الرئيسي: | Mokhbat, J. (author) |
|---|---|
| مؤلفون آخرون: | Naman, R. (author), Klayme, S. (author), Naboulsi, M. (author), Jradi, O. (author), Ramia, S. (author) |
| التنسيق: | article |
| منشور في: |
2002
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/5232 http://dx.doi.org/10.1053/jinf.2002.1006 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://www.sciencedirect.com/science/article/pii/S0163445302910066 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1–infected leukemic cells
حسب: Nasr, Rihab
منشور في: (2003) -
Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes
حسب: Rizk, Sandra
منشور في: (2011) -
Zidovudine and interferon-α treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran
حسب: Kchour, Ghada
منشور في: (2009) -
Incidence, predictors and severity of adverse events among whole blood donors
حسب: Almutairi, Hamdan
منشور في: (2017) -
Value Co-Creation using Activity Theory: Cord Blood Donor Recruitment in Hospitals
حسب: ALHASHIMI, FATMA HUSSAIN
منشور في: (2018)